My Life, Our Future: Genotyping for Progress in Hemophilia | NHLBI Trans-Omics for Precision Medicine Skip to main content

My Life, Our Future: Genotyping for Progress in Hemophilia

Short Name
MLOF
Institution(s)
Blood Works Northwest
Type of Omics
WGS
RNASeq
Approx. Sample Size 2188 (ph2), 2959 (ph3)
Disease/Phenotype
Hemophilia
Starting Phase
Phase 2
dbGaP ID
TOPMed Accession #
Please see this TOPMed Project's Parent Studies.
Omics Center(s) Phase 2
New York Genome Center Genomics
Omics Center(s) Phase 3
Baylor College of Medicine Human Genome Sequencing Center
Omics Center(s) Phase 6
Baylor College of Medicine Human Genome Sequencing Center
Northwest Genomics Center
Phases Involved
2
3
6
Populations
Males and Females of All Ages with Hemophilia A
PI
Co-PI
Contact
NIH Program Officer
Phenotype Liaison
Steering Committee Representatives
P&P primary
P&P alternate
Project
MLOF
Released
No
Back to top